Strategic Consulting and Advisory Services
Certara is the largest and most comprehensive provider of biosimulation (modeling and simulation), strategic pharmacometrics, and regulatory writing consulting services. Our multidisciplinary team works alongside clients to inform key drug development decisions and expedite the processes around achieving regulatory milestones.
Software Portfolio: 'End-to-end' Modeling
Certara biosimulation (model based drug development and informatics) software portfolio is the most wide-ranging in the industry. Certara technology is relied upon by over 1,500 biopharm companies and academic institutions for drug research and development.
Certara's Programmatic Consulting Approach Delivers Unquestionable Value to Sponsor Companies
Certara combines its industry renowned pharmacometric and regulatory consultants with our vast software portfolio to provide services that focus on specific outcomes, therapeutic areas, regulatory milestones, and specific populations.
Leading Edge Science: Resource Library
Check out the latest brochures, case studies, white papers, webinars, and more! Search by keywords and/or filter results.
Certara Appoints Tristen Herrstrom as Senior Vice President of Human Resources
July 16, 2015
Ms. Herrstrom will focus on enhancing talent acquisition, leadership development, and other key growth initiatives.
PRINCETON, NJ – July 16, 2015 – Certara®, the global biosimulation technology-enabled drug development company, today announced that it has appointed Tristen Herrstrom to the newly-created position of senior vice president of human resources.
With responsibility for establishing the strategic direction of Certara’s ‘people management,’ Ms. Herrstrom will focus on enhancing talent acquisition, leadership development, and other key growth initiatives. She will be based at Certara’s Princeton, NJ headquarters and report to the company’s Chief Executive Officer Edmundo Muniz, M.D., Ph.D.
“This is an exciting time for Certara. The biosimulation and regulatory writing markets are blossoming. As a result, we are rapidly hiring talented new staff and acquiring or merging with companies whose skills and expertise enhance our own. In just over a year, more than 100 talented individuals from Synchrogenix, ClinGenuity and Quantitative Solutions have each joined our passionate and visionary team,” said Dr. Muniz.
“Now is the perfect time for Tristen to join Certara. She will help us to maximize this incredible opportunity by ensuring that we have the right staff in place and that our new colleagues feel part of our team. I am delighted to have her on board,” he added.
Ms. Herrstrom brings 20 years of experience leading, integrating and building human resource, talent acquisition, and real estate functions in healthcare and pharmaceutical service organizations.
“Certara is perfectly positioned to satisfy biopharma clients’ growing demand for model-based drug development and regulatory writing support,” said Ms. Herrstrom. “The company’s entrepreneurial culture and history of scientific leadership make it an ideal platform for growth. I am excited to be able to play a pivotal role in Certara’s and its customers’ success.”
Prior to joining Certara, Ms. Herrstrom served as chief resource officer for QualCare Alliance Networks, Inc., and before that for inVentiv Health. In those roles, she was responsible for all resource management functions, including human resources, talent acquisition, facility management, and ensuring synergy in company programs, polices, and practices. During her time at inVentiv Health, she successfully integrated more than 25 acquired companies.
Tristen earned an MS in Human Resource Counseling from Northeastern University.
About Certara
Certara is a global biosimulation technology-enabled drug development company. Its customers include hundreds of biopharmaceutical companies around the globe, together with several regulatory agencies. Certara’s solutions, which span the discovery, preclinical and clinical stages of drug development, enable data-driven decisions, leading to more precisely designed trials with a reduced risk of failure and improved subject safety. For more information, visit www.certara.com.
Certara Contact:
Ellen Leinfuss, 609-216-9586
Chief Marketing Officer
Media Contact:
Lisa Osborne, 206-992-5245
Rana Healthcare Solutions
lisa@ranahealth.com